Clinical Trial Update: Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES)

View source ↗

Summary

Clinical trial update on the GENOSS DES sirolimus-eluting stent, assessing its effectiveness and safety in patients with coronary artery disease undergoing perc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• GENOSS DES sirolimus-eluting stent (sirolimus)

Snippet

Sponsor: Genoss Co., Ltd. | Conditions: Coronary Artery Disease, Percutaneous Coronary Intervention | Status: ENROLLING_BY_INVITATION